STAT

Opinion: Who missed the chance to stop the CRISPR babies scientist? Look in the mirror

It's inconceivable that a researcher with years of education and training failed to follow basic professional responsibilities to conduct research in an ethically responsible manner.
Source: Mark Schiefelbein/AP

The reported birth of genetically altered twins using CRISPR-Cas9 genetic modification technology has rightly drawn widespread condemnation for a host of reasons. I’d like to join that chorus and focus on what this reprehensible episode says about the research culture and the educational system that helps shape it.

It’s easy to think of He as an outlier, a rogue scientist following a solitary path to unethical research. But that isn’t the case. Before taking an academic position at the Southern University of Science and Technology of China in Shenzhen, He completed his doctoral work at and his post-doctoral work at Stanford University, two premier U.S. biomedical research institutions.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Moderna Covid-flu Vaccine, A Paused Pfizer Study, And More
Moderna announced its combination Covid and flu vaccine generated stronger immune responses in older adults in a Phase 3 trial than individual vaccines.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Novo’s Wegovy Approval In China, A Merck KGaA Cancer Trial Failure, And More
Novo Nordisk's weight loss drug Wegovy has been approved in China, the country estimated to have the highest number of overweight or obese people.
STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.

Related Books & Audiobooks